Exemplar Compliance, LLC announces new CEO
Release Date: 15 May 2020
Exemplar Compliance, LLC is pleased to announce the appointment of Gary Knight as the organization’s next president and chief executive officer. Gary brings a wealth of knowledge and experience to the position, primarily in the pharmaceutical industry, both on a national and global level.
Gary Knight will be overseeing all global consulting operations and setting the vision for the company’s expansion into supply chain logistics, medical devices, and digital health. He is joined by Kimberly Snyder, Executive Vice President of Quality, Regulatory, and Compliance, and Gaia Maurer, Vice President of Supply Chain Management.
Gary has previously held senior positions at GKI, Inc, Commissioning Agents, Inc., and The United States Navy. Prior to joining Exemplar Compliance Dr. Knight was the President and CEO of GKI, Inc., an independent consulting firm serving the pharmaceutical and biotech industries.
Gary feels this is a tremendous opportunity to take a leading life science consulting company to the next level. “Exemplar Compliance is already well known in the life science space for outstanding quality consulting. My goal is to grow the company into something even stronger than it is today. Rebecca has been an extraordinary leader and I am excited to take over for her and lead such an important company in this critical time.”
Rebecca Waterbury, now Board Member at Exemplar Compliance, says, ”This is an important step in the evolution of the company. Gary’s passion for innovation and technology will help our business grow. He has been a supporter of Exemplar Compliance for years and understands the underlying quality and value that we deliver to pharmaceutical and life science companies. He will be able to expand our services while staying true to our core values. This will be a huge advantage for our customers.”
About Exemplar Compliance
Exemplar Compliance is an international consulting firm offering full-service solutions to companies in the Life-Science space including Pharmaceutical, Biotech, Medical Device, IVD, and Nutritionals. Founded in 2011, its mission has been to provide practical quality and compliance solutions to the life-science industry. In their 9 year history they have worked with many clients across the globe. They have helped to bring numerous products to market including cancer treatments, Alzheimer’s medications, animal medicines, stents, heart medications, in vitro diagnostic testing kits, diabetes medications, and medical software. Their core business has been quality and regulatory compliance consulting including Quality System Development, mergers and acquisitions, FDA response and remediation, and new product launch.
Dr. Gary Knight